INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/25/2026
Back to search
Official data from USPTO
ALTAVOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
07/25/2026
Trademark type
Word
Nice classes
5, 10
Filing date
01/15/2024
Registration date
07/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
DUBIN, DAVID I
Law office
L70
Current location
Historical data usage
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 10
Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosispreventiontreatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosispreventiontreatment of hematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosispreventiontreatment of eye diseases and eye conditions; medical apparatus and instruments for the diagnosispreventiontreatment of heart rhythm disorders; medical apparatus and instruments for the diagnosispreventiontreatment of immune system diseases and disorders; medical apparatus and instruments for the diagnosispreventiontreatment of kidney diseases; medical apparatus and instruments for the diagnosispreventiontreatment of diabetes; medical apparatus and instruments for the diagnosispreventiontreatment of hypertension; medical apparatus and instruments for the diagnosispreventiontreatment of skin disorders; medical apparatus and instruments for the diagnosispreventiontreatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosispreventiontreatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosispreventiontreatment of cancer and tumors; medical apparatus and instruments for the diagnosispreventiontreatment of allergies; medical apparatus and instruments for the diagnosispreventiontreatment of bone diseases; medical apparatus and instruments for the diagnosispreventiontreatment of respiratory diseases and asthma; radiological apparatus for medical purposes and instruments being radiological apparatus for medical purposes; genetic testing apparatus for medical purposes and instruments being genetic testing apparatus for medical purposes; electromagnetic drug delivery apparatus for medical use and instruments being electromagnetic drug delivery apparatus for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments being medical diagnostic apparatus for testing DNA and RNA samples for medical use; medical apparatusinfusion and injection devices for administering drugs; medical apparatus and instruments being medical apparatus for introducing pharmaceutical preparations into the human body
Publications
History of USPTO decisions and trademark events.
43 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/10/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/12/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/19/2026
FIMP
FINAL DISPOSITION PROCESSED
02/19/2026
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/19/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
12/02/2025
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
11/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/24/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/08/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
08/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/09/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/13/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
03/31/2025
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2025
RFNT
REFUSAL PROCESSED BY IB
01/17/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2025
RFRR
REFUSAL PROCESSED BY MPU
01/02/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/17/2024
CNRT
NON-FINAL ACTION WRITTEN
12/16/2024
DOCK
ASSIGNED TO EXAMINER
08/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/29/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/29/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/29/2024
MAFR
APPLICATION FILING RECEIPT MAILED
05/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/21/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/15/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/10/2024
Continuous trademark protection
Get notified about every new filing that threatens ALTAVOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.